Cent Eur J Public Health 2020, 28(3):219-225 | DOI: 10.21101/cejph.a5611
Quality of life of patients with psoriasis
- 1 Department of Hygiene and Preventive Medicine, Faculty of Medicine in Hradec Králové, Charles University, Hradec Králové, Czech Republic
- 2 Department of Pathological Physiology, Faculty of Medicine in Hradec Králové, Charles University, Hradec Králové, Czech Republic
- 3 Department of Dermatology and Venerology, Faculty Hospital Hradec Králové, Hradec Králové, Czech Republic
- 4 Department of Social Medicine, Faculty of Medicine in Hradec Králové, Charles University, Hradec Králové, Czech Republic
- 5 Computer Technology Centre, Faculty of Medicine in Hradec Králové, Charles University, Hradec Králové, Czech Republic
Objective: The two main aims of our study were to assess the quality of life (QOL) of patients with moderate or severe psoriasis treated by Goeckerman therapy and to compare QOL of our patients on the date of admission and 1 month after their discharge.
Methods: We performed a prospective study on 51 patients treated for chronic plaque psoriasis by Goeckerman regimen (GR). The psoriasis area involvement and severity was measured using the Psoriasis Area and Severity Index (PASI). Patients' health-related QOL was evaluated using Psoriasis Disability Index (PDI).
Results: In our study we demonstrated that the QOL of this sample of 51 patients with severe forms of psoriasis was relatively good; an average PDI value on the day of admission was 9.02, which represents a small effect on patient's QOL. We did not find any significant differences in QOL between younger and older respondents or between men and women. Despite good treatment efficiency, we did not find improvement in QOL 1 month after discharge.
Conclusions: The QOL of our patients was relatively good. This could be explained by the fact that our patients have been suffering from psoriasis for many years and have probably adapted to their disease. QOL of our patients was not directly dependent on the extent and intensity of skin changes. Further studies on the connection between psoriasis therapy and patients' QOL are still highly needed.
Keywords: psoriasis, quality of life, Goeckerman therapy
Received: November 15, 2018; Revised: June 8, 2020; Accepted: June 8, 2020; Published: September 30, 2020 Show citation
References
- Puig L, Thom H, Mollon P, Tian H, Ramakrishna GS. Clear or almost clear skin improves the quality of life in patients with moderate-to-severe psoriasis: a systemic review and meta-analysis. J Eur Acad Dermatol Venerol. 2017;31(2):213-20.
Go to original source...
Go to PubMed...
- Sojević Timotijević Z, Majcan P, Trajković G, Relić M, Novaković T, Mirković M, et al. The impact of changes in psoriasis area and severity index by body region on quality of life in patients with psoriasis. Acta Dermatovenerol Croat. 2017;25(3):215-22.
Go to PubMed...
- De Arruda LH, De Morales AP. The impact of psoriasis on quality of life. Br J Dermatol. 2001;144 Suppl 58:33-6.
Go to original source...
- Krueger G, Koo J, Lebwohl M, Menter A, Stern RS, Rolstad T. The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol. 2001;137(3):280-4.
Go to PubMed...
- Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB, Gelfand JM. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol. 2006;55(5):829-35.
Go to original source...
Go to PubMed...
- Sarkar R, Chugh S, Bansal S. General measures and quality of life issues in psoriasis. Indian Dermatol Online J. 2016;7(6):481-8.
Go to original source...
Go to PubMed...
- Vardy D, Besser A, Amir M, Gesthalter B, Biton A, Buskila D. Experiences of stigmatization play a role in mediating the impact of disease severity on quality of life in psoriasis patients. Br J Dermatol. 2002;147(4):736-42.
Go to original source...
Go to PubMed...
- Schmitt JM, Ford DE. Role of depression on quality of life for patients with psoriasis. Dermatology. 2007;215(1):17-27.
Go to original source...
Go to PubMed...
- Rapp SR, Feldman SR, Exum ML, Fleischer AB Jr, Reboussin DM. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol. 1999;41(3 Pt 1):401-7.
Go to original source...
Go to PubMed...
- McKenna SP, Cook SA, Whalley D, Doward LC, Richards HL, Griffiths CE, et al. Development of the PSORIQoL, a psoriasis-specific measure of quality of life designed for use in clinical practice and trials. Br J Dermatol. 2003;149(2):323-31.
Go to original source...
Go to PubMed...
- Lee E, Koo J. Modern modified 'ultra' Goeckerman therapy: a PASI assessment of a very effective therapy for psoriasis resistant to both prebiologic and biologic therapies. J Dermatolog Treat. 2005;16(2):102-7.
Go to original source...
Go to PubMed...
- Chern E, Yau D, Ho JC, Wu WM, Wang CY, Chang HW, et al. Positive effect of modified Goeckerman regimen on quality of life and psychosocial distress in moderate and severe psoriasis. Acta Derm Venereol. 2011;91(4):447-51.
Go to original source...
Go to PubMed...
- Dennis M, Bhutani T, Koo J, Liao W. Goeckerman therapy for the treatment of eczema: a practical guide and review of efficacy. J Dermatolog Treat. 2013;24(1):2-6.
Go to original source...
Go to PubMed...
- Finlay AY, Coles EC. The effect of severe psoriasis on the quality of life of 369 patients. Br J Dermatol. 1995;132(2):236-44.
Go to original source...
Go to PubMed...
- Balaątík D, Semrádová V. Distribution of some variables in the sample of psoriatics and their modification by group psychotherapy. Ceskoslov Psychol. 2007;51(2):183-97. (In Czech.)
- Abrouk M, Nakamura M, Zhu TH, Farahnik B, Koo J, Bhutani T. The impact of PASI 75 and PASI 90 on quality of life in moderate to severe psoriasis patients. J Dermatolog Treat. 2017;28(6):488-91.
Go to original source...
Go to PubMed...
- He Z, Lu C, Ou A, Fang J, Wang D, Deng J, et al. Reliability and validity of the Chinese version of the Psoriasis Disability Index (PDI) in Chinese patients with psoriasis. Health Qual Life Outcomes. 2012;10:37. doi: 10.1186/1477-7525-10-37.
Go to original source...
Go to PubMed...
- Mahmutovic J, Zukic M, Pasalic A, Brankovic S, Jaganjac A, Katana B. Correlation between quality of life and depression among persons suffering from psoriasis. Med Arch. 2017;71(5):341-6.
Go to original source...
Go to PubMed...
- Lee YW, Park EJ, Kwon IH, Kim KH, Kim KJ. Impact of psoriasis on quality of life: relationship between clinical response to therapy and change in health-related quality of life. Ann Dermatol. 2010;22(4):389-96.
Go to original source...
Go to PubMed...
- Semrádová V, Balaątík D. The quality of life measurement in patients with psoriasis. Ceskoslov Dermatol. 2003;78(6):228-31. (In Czech.)
- Semrádová V, Vaąků V, Balaątík D, Slonková V. Quality of life in patients with psoriasis vulgaris. I. The impact of therapy on the quality of life. Ceskoslov Dermatol. 2006;81(3):153-61. (In Czech.)
- Fortune DG, Richards HL, Main CJ, Griffiths CE. Patients' strategies for coping with psoriasis. Clin Exp Dermatol. 2002;27(3):177-84.
Go to original source...
Go to PubMed...
- Gelfand JM, Feldman SR, Stern RS, Thomas J, Rolstad T, Margolis DJ. Determinants of quality of life in patients with psoriasis: a study from the US population. J Am Acad Dermatol. 2004;51(5):704-8.
Go to original source...
Go to PubMed...
- McKenna KE, Stern RS. The impact of psoriasis on the quality of life of patients from the 16-center PUVA follow-up cohort. J Am Acad Dermatol. 1997;36(3 Pt 1):388-94.
Go to original source...
Go to PubMed...
- Naldi L, Mercuri SR. Epidemiology of comorbidities in psoriasis. Dermatol Ther. 2010;23(2):114-8.
Go to original source...
Go to PubMed...